BioServe Selected by Specialized Clinical Center of Research for Study on Thoracic Aortic Disease

BELTSVILLE, MD--(MARKET WIRE)--Jun 18, 2007 -- BioServe today announced that it has been selected by Houston-based Specialized Clinical Center of Research (SCCOR) for a novel study aimed at identifying the genetic cause of thoracic aortic disease. The SCCOR is a collaborative program by University of Texas Health Science Center Houston, Baylor College of Medicine and University of Texas Medical Branch. Under terms of the agreement, BioServe will provide the SCCOR researchers with access to certain unique sample sets from its Global Repository of over 600,000 human DNA, tissue and serum samples linked to detailed clinical and demographic data to assist in identifying genes that are predictive of the development and progression of thoracic aortic diseases. Thoracic aortic disease is the 15th leading cause of death in the United States, with aortic dissections being the 13th leading cause of death in people between the ages of 55 and 64.

MORE ON THIS TOPIC